| Dr Pamela M Powers, MD | |
|
483 W Seed Farm Rd, Sacaton, AZ 85247 | |
| (602) 528-1340 | |
| (602) 528-1296 |
| Full Name | Dr Pamela M Powers |
|---|---|
| Gender | Female |
| Speciality | Psychiatry & Neurology - Psychiatry |
| Location | 483 W Seed Farm Rd, Sacaton, Arizona |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1760452882 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2084P0800X | Psychiatry & Neurology - Psychiatry | 19221 (Arizona) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Pamela M Powers, MD Po Box 115, Sacaton, AZ 85247-0115 Ph: (602) 528-1340 | Dr Pamela M Powers, MD 483 W Seed Farm Rd, Sacaton, AZ 85247 Ph: (602) 528-1340 |
News Archive
Miracor Medical Systems GmbH announced today that the company has received CE-mark for the PICSO® (Pressure-controlled Intermittent Coronary Sinus Occlusion) Impulse System, designed to improve acute coronary syndrome (ACS) revascularization following primary percutaneous coronary intervention (PCI).
Exelixis, Inc. today announced that the U.S. Food & Drug Administration (FDA) has granted orphan drug designation to XL184 for treatment of follicular, medullary, and anaplastic thyroid carcinoma, and metastatic or locally advanced papillary thyroid cancer. A pivotal phase 3 trial of XL184 is ongoing in patients with medullary thyroid cancer (MTC) and the company expects to release top-line phase 3 results in the first-half of 2011 and potentially file a New Drug Application (NDA) for the compound in the second-half of 2011.
Difficult-to-study diseases such as Alzheimer's, schizophrenia, and autism now can be probed more safely and effectively thanks to an innovative new method for obtaining mature brain cells called neurons from reprogrammed skin cells. According to Gong Chen, the Verne M. Willaman Chair in Life Sciences and professor of biology at Penn State University and the leader of the research team, "the most exciting part of this research is that it offers the promise of direct disease modeling, allowing for the creation, in a Petri dish, of mature human neurons that behave a lot like neurons that grow naturally in the human brain."
Emergent Financial Group, Inc. today announced the completion of a $11.8 million private placement transaction for Tenex Health Inc., a California-based medical technology company developing the FAST Procedure (Focused Aspiration of Scar Tissue) for the treatment of tendon injuries.
› Verified 2 days ago
Dr. Audrey A Kanwischer, D.O. Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 483 W. Seed Farm Rd., Sacaton, AZ 85247 Phone: 602-528-1340 Fax: 602-528-1296 | |
Ms. Eden Enriquez Johnson, MD Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 198 S Skill Center Rd, Sacaton, AZ 85247 Phone: 888-431-4096 Fax: 520-562-3415 |